Latest for Ataxia-Telangiectasia
See all trialsThe week in rare diseaseEach date is the day a change was posted. Open an item to see where things stand now.
- FDA decisionFDA approved Aqneursa for Ataxia-telangiectasiaFDA
More about Ataxia-Telangiectasia
Without it, damage accumulates. The cells that suffer most are the Purkinje cells of the cerebellum, the part of the brain that coordinates movement, and they die off progressively through childhood. That is the ataxia: gait, balance, speech, eye movements and hand control all deteriorate as the cerebellum shrinks, even though muscle strength itself is preserved for a long time.
Keep reading about Ataxia-Telangiectasia
The same defect explains everything else about the disease. Immune cells that need to rearrange their own DNA to make antibodies do it poorly, so most people with A-T have low antibody levels and get repeated respiratory infections. Lung disease and cancer are the main causes of death, and a 2022 review of published A-T cases (Petley et al., PLOS One) found cancer was the cause reported most often.
Because damaged DNA is not repaired, the risk of cancer, above all leukemia and lymphoma, is many times higher than in the general population, and the same fragility makes patients dangerously sensitive to radiation, including standard X-ray doses and some chemotherapy. Blood levels of alpha-fetoprotein are raised in nearly everyone with A-T, which makes it a useful screening test when a child's unsteadiness has no obvious explanation.
Genetic testing of ATM confirms the diagnosis.
What are the symptoms of Ataxia-Telangiectasia?
These are common symptoms of Ataxia-Telangiectasia, and how strong they are varies from person to person.
- Unsteady walking and poor balance appearing before age 5, after a normal start
- Slurred speech and difficulty moving the eyes from side to side (oculomotor apraxia)
- Involuntary jerking movements and tremor that worsen over time
- Tiny dilated blood vessels (telangiectasias) on the whites of the eyes and skin, usually by age 5 to 8
- Frequent sinus and lung infections from a weakened immune system
- Difficulty swallowing and slowed growth in later childhood
Who gets Ataxia-Telangiectasia?
A-T is autosomal recessive: both parents carry one non-working copy of ATM without symptoms, and each pregnancy has a 1 in 4 chance of an affected child. It affects boys and girls equally and every ethnic group. Toddlers usually walk on time and then begin to wobble, and the diagnosis often takes years because early A-T looks like cerebral palsy. Most children need a wheelchair by around age 10. Life expectancy varies widely and has lengthened with better infection and cancer care, but most people with A-T live into early adulthood rather than beyond it.
Next steps: find trials you might fitsee approved treatmentsget help payingget alerts
Which medicines are FDA-approved for Ataxia-Telangiectasia?
There is currently 1 FDA-approved medication for Ataxia-Telangiectasia.
Source: openFDA drug labeling data. This list may not include all treatments. Always consult your doctor.
How to get help paying for Ataxia-Telangiectasia treatment
Charity funds and drugmaker programs for Ataxia-Telangiectasia, checked at the source.
Side effects people have reported to the FDA
Side effects people have reported to the FDA
Real-world side effect reports from the FDA Adverse Event Reporting System (FAERS). Includes both FDA-approved drugs and investigational therapies from active clinical trials. Click any drug to see what patients reported.
Loading side effect data...
Diagnosis and genetic testing
Genetic testing for Ataxia-Telangiectasia
Genetic testing can confirm a diagnosis, guide treatment decisions, and identify family members who may be at risk.
Finding labs...
Trusted Ataxia-Telangiectasia resources
Reputable organizations and medical references for learning more about Ataxia-Telangiectasia, including disease registries, foundation resources, and clinical guidelines.